Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease
BelgiumStudy on the Effectiveness and Safety of Mitapivat for Patients with Sickle Cell Disease
BelgiumStudy of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant
BelgiumStudy of Nivolumab and Ipilimumab for Patients with Type B3 Thymoma and Thymic Carcinoma After Chemotherapy
BelgiumStudy on the Effectiveness and Safety of Rozanolixizumab for Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOG-AD)
BelgiumStudy Comparing Pemigatinib and Gemcitabine Plus Cisplatin for First-Line Treatment in Patients with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Rearrangement
BelgiumStudy Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant
BelgiumStudy Comparing Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin versus High-Dose Chemotherapy with Paclitaxel and Drug Combination for Relapsed Germ Cell Tumors
BelgiumStudy of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality
BelgiumStudy of Regorafenib and Nivolumab with radiotherapy for patients with stage II-III rectal cancer before surgery
BelgiumStudy of BMS-986446 for Early Alzheimer's Disease Patients
BelgiumStudy of QEL-001 (CAR T regulatory cell therapy) to prevent liver transplant rejection in patients with HLA-A2 positive donor organ
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
